Polyclonal antilymphocyte sera induce immune activation in human renal allograft recipients.
Book
B
B
Department of Surgery, Indiana University Medical Center, Indianapolis 46202, USA.
Pescovitz
M
M
Leapman
S
S
Filo
R
R
D000276:Adjuvants, Immunologic; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D015703:Antigens, CD / Q000096:biosynthesis; D000945:Antigens, Differentiation, T-Lymphocyte / Q000096:biosynthesis; D000961:Antilymphocyte Serum / Q000494:pharmacology / Q000627:therapeutic use*; D001831:Body Temperature / Q000187:drug effects; D002478:Cells, Cultured; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000096:biosynthesis; D016030:Kidney Transplantation / Q000276:immunology*; D037181:Lectins, C-Type; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D014184:Transplantation, Homologous; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis; D000099192:CD69 Antigens
D000276:Adjuvants, Immunologic; D000305:Adrenal Cortex Hormones; D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D037181:Lectins, C-Type; D014409:Tumor Necrosis Factor-alpha; D000099192:CD69 Antigens